Cancer Clinical Trials Information Platform in Hong Kong
-
This serves merely as an information platform about cancer clinical trials operated by different institutions in Hong Kong. HKACS is not responsible for the contents, availability and operability of the trials listed.
- Respective institutions usually reserve all rights regarding the implementation and execution of their respective clinical trials.
- Patients usually need to satisfy a complex and stringent set of selection criteria before being selected/ included in certain clinical trials. Interested parties should contact respective institutions regarding further details of the trials
*in alphabetical order (Last updated on 03/10/2024)
Institution |
Study Title |
|
HKU |
(TAS-102) Phase II Trial of TAS-102 in Patients with Advanced, Refractory Pancreatic Adenocarcinoma |
Click for Details |
For Enquiry, please contact the respective institute, HKACS is not responsible for the outcomes of the clinical trials.